[The 'Phadiatop Paediatric': a useful in-vitro test on an atopic immune response in infants and young children]

A W van Toorenenbergen1, A P Oranje, A M Vermeulen

  • 1Afd. Klinische Chemie, laboratorium Allergologie, Academisch Ziekenhuis Rotterdam-Dijkzigt.

Insights

Phadiatop Paediatric is a new test for screening IgE antibodies in children. This study found it effectively identifies allergies in young children, suggesting underdiagnosis in some cases.

Area of Science:

  • Pediatric Allergy and Immunology
  • Diagnostic Test Evaluation
  • Immunoglobulin E (IgE) Antibody Testing

Context:

  • Allergic diseases are prevalent in infants and children.
  • Accurate and early diagnosis of IgE-mediated allergies is crucial for effective management.
  • Existing diagnostic methods may sometimes underdiagnose allergic responses in young children.

Purpose:

  • To evaluate the diagnostic performance of a new screening test, Phadiatop Paediatric, for IgE antibodies in children.
  • To compare Phadiatop Paediatric results with conventional RAST (Radioallergosorbent test) assays.
  • To assess the potential for underdiagnosis of allergies using standard testing protocols.

Summary:

  • Phadiatop Paediatric, containing relevant food and inhalant allergens for children, was tested on 180 sera from children under five.
  • The test showed a higher positive rate (135 sera) compared to combined Phadiatop and mixed-food-RAST (116 sera).
  • 22% of sera negative by initial physician-requested RASTs were positive by both Phadiatop Paediatric and a mixed-food-RAST, indicating potential underdiagnosis.

Impact:

  • Phadiatop Paediatric demonstrates potential as a sensitive screening tool for pediatric allergies.
  • The findings suggest that this new test can identify IgE antibody responses missed by conventional RASTs.
  • Improved allergy screening in children can lead to earlier intervention and better health outcomes.

Related Concept Videos